The Pharma & Healthcare industry is of vital importance for human and economic development, providing a wide range of goods and services relevant to the promotion of health at all stages in the healthcare process – from prevention and treatment to rehabilitation and palliative care. It is one of the fastest-growing industries, supported by profound demographic changes, the rising incidence of non-communicable diseases, and surging per capita health spending in both developed and emerging markets. The industry is also one of the major innovators, with increasing expenditures on development of new molecules, biotechnology and adoption of new technologies that provide advanced healthcare and ensure the longevity of the population.
The Pharma & Healthcare industry comprises the manufacture of pharmaceuticals for human and veterinary use, medical equipment and related supplies. It also includes providers of ambulatory health services, medical and diagnostic laboratories, hospitals, and nursing and residential care facilities.
Russia’s healthcare expenditure grew significantly in 2020, mainly reflecting increased spending related to the COVID-19 pandemic. Total spending on healthcare surged by nearly a fifth to RUB 6.2tn in 2020, equal to 5.8% of the country’s ...
View more detailsMalaysia has a highly developed pharmaceuticals and healthcare sector. Malaysia’s healthcare system is two-tiered. The Ministry of Health (“MoH”) provides comprehensive, taxpayer-funded healthcare services for Malaysian ...
View more detailsIn Q3 2021, Chinese residents’ expenditures on medicine and medical services continued to increase. Per capita spending of urban residents reached RMB 635, up by 10.8% y/y, and that of rural residents recorded a growth of 9 ...
View more detailsAs the global epidemic is being contained and China’s economic growth has returned to normal, the growth of the country's healthcare sector is likely to gradually slow down to pre-pandemic levels. In the second quarter of 2021, the ...
View more detailsIndia’s pharmaceuticals and healthcare sector has been dominated by a second wave of COVID-19 infections beginning in April 2021 driven by the Delta variant. The surge caught the Indian government and the pharmaceuticals and ...
View more detailsChina's healthcare system is hospital-centric, and most of the inpatient and outpatient care in the country is delivered in public hospitals and basic medical institutions. However, due to the growing demand ...
View more detailsSince China initiated 5G technology R&D and standard formulation in 2013, the landmark national-level policy has been Made in China 2025 issued by the State Council in 2015. 5G technology, along with integrated circuits ...
View more detailsChina’s successful recovery from the COVID-19 outbreak back in mid-2020 had a positive effect on its economic performance as well as on separate sectors, including healthcare. China’s GDP managed to return to a usual pre-pandemic ...
View more detailsIndia is a world leader in the production and export of generic pharmaceuticals, accounting for approximately 20% of the global volume of generic drug sales. Despite its export markets success, India’s pharmaceuticals and healthcare ...
View more detailsThe Philippines pharmaceuticals and healthcare sector is entering a phase of accelerated growth. The Philippines economy has grown considerably over the recent years, creating a growing middle-class population with the means to access ...
View more details